Arbutus Biopharma Corp (NASDAQ: ABUS) kicked off on Monday, up 4.04% from the previous trading day, before settling in for the closing price of $3.22.
On Friday, Arbutus Biopharma Corp (NASDAQ: ABUS) was -3.35% drop from the session before settling in for the closing price of $3.28. A 52-week range
Arbutus Biopharma Corp (NASDAQ: ABUS) kicked off on Monday, down -3.09% from the previous trading day, before settling in for the closing price of $3.24.
As on Thursday, Arbutus Biopharma Corp (NASDAQ: ABUS) got off with the flyer as it spiked 1.57% to $3.24, before settling in for the price
On Tuesday, Arbutus Biopharma Corp (NASDAQ: ABUS) was -1.17% drop from the session before settling in for the closing price of $3.41. A 52-week range
Arbutus Biopharma Corp (NASDAQ: ABUS) kicked off on Tuesday, down -3.63% from the previous trading day, before settling in for the closing price of $3.58.
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.